For instance, the transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) is vital to stimulate the PC initiation and maintain proliferation by regulating mRNA translation, which makes the NRF2 ablation a promising strategy for the treatment of PC (Chio et al., 2016). The gene discussed is NFE2L2; the disease is pachyonychia congenita.